NCT06663241

Brief Summary

The purpose of this study is to determine the validity of a new photographic technology in a dermatologic setting. The digital picture uses high levels of resolution to look at skin biopsy lesions. These photos will be compared to current standard-of-care with hematoxylin and eosin histologic analysis by board-certified dermatologists.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed
Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

10 months

First QC Date

October 18, 2024

Last Update Submit

February 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of matching dermatologic diagnoses from photography to biopsied lesions.

    A group of board-certified dermatologists will evaluate the standard digital vs. enhanced digital photograph of the lesion to compare the accuracy of diagnoses to the pathology report, with pathology serving as the gold standard.

    At time of biopsy procedure of the lesion.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Wright State Physicians Dermatology Clinic

You may qualify if:

  • Adult patients ages 18 and older.
  • Able to comprehend procedures, risks, and informed consent.
  • Have a skin lesion the practitioner believes, and subject agrees, should be biopsied.
  • Lesion on a non-revealing part of the body (none on areas that would be recognizable, nor on groin nor breasts).
  • Willingness of subject to share the results of the biopsy pathology.

You may not qualify if:

  • Lesion on a revealing part of body.
  • Unable to understand the procedures, informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wright State Physicians

Fairborn, Ohio, 45324, United States

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2024

First Posted

October 29, 2024

Study Start

February 15, 2023

Primary Completion

December 20, 2023

Study Completion

December 20, 2023

Last Updated

February 6, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations